Metformin Cost in Alaska (2026): Prices, Insurance, Medicaid, and Savings

Prescription access and medication affordability image for Metformin Cost in Alaska (2026): Prices, Insurance, Medicaid, and Savings

How Much Does Metformin Cost in Alaska in 2026?

At a glance

  • Average Alaska cash price / $8 per month (generic, 2026)
  • Manufacturer list price / ~$40 per month
  • Standard dosing / 500 mg to 2 to 000 mg daily, oral tablet, taken with food
  • Alaska Medicaid / does not cover metformin
  • Private insurance / most plans cover generic metformin at tier 1
  • Medicare Part D / typically $0 to $10 copay
  • Compounded metformin / available via licensed 503A pharmacies in Alaska
  • Telehealth prescribing / legal in Alaska
  • GoodRx or RxSaver coupon price / often $4 to $6 for 30-day supply
  • FDA-approved indications / type 2 diabetes; prescribed off-label for prediabetes and PCOS

Alaska Retail Pharmacy Prices for Metformin

The average cash price for a 30-day supply of generic metformin at Alaska retail pharmacies is approximately $8 in 2026. That figure sits far below the $40 manufacturer list price and makes metformin one of the least expensive prescription medications available in the state. Prices vary by pharmacy chain, location, and tablet strength.

Metformin hydrochloride has been off-patent since 2002, and dozens of generic manufacturers supply the U.S. market. This competition keeps prices low. A 2012 analysis in the Annals of Internal Medicine found that metformin ranked among the most cost-effective diabetes therapies in the United States, with annual per-patient drug costs under $100 in many settings [1]. Alaska pharmacies reflect this national pattern. Walmart, Costco, Fred Meyer, and independent pharmacies in Anchorage, Fairbanks, and Juneau typically stock 500 mg and 850 mg immediate-release tablets and 500 mg or 750 mg extended-release formulations. Extended-release versions may cost $2 to $5 more per month than immediate-release at some locations.

Patients paying out of pocket should compare prices across at least two or three pharmacies. Rural Alaska communities served by smaller pharmacies or tribal health facilities may see different pricing structures. The Indian Health Service (IHS) and tribal health organizations, including the Alaska Native Tribal Health Consortium (ANTHC), provide metformin at no cost to eligible Alaska Native and American Indian patients through the federal supply system [2].

Alaska Medicaid and Metformin Coverage

Alaska Medicaid does not currently cover metformin. This is an unusual gap. Most state Medicaid programs include metformin on their preferred drug lists because the American Diabetes Association (ADA) designates it as first-line pharmacotherapy for type 2 diabetes [3].

Patients enrolled in Alaska Medicaid who need metformin face a few options. They can pay the $8 average cash price, use a pharmacy discount card, or request a prior authorization. Some Alaska Medicaid managed care organizations may process exceptions for drugs not on the standard formulary if the prescribing clinician documents medical necessity. The ADA's 2024 Standards of Care recommend metformin as initial therapy for most adults with type 2 diabetes and an HbA1c at or above 6.5%, noting its established cardiovascular benefit profile first demonstrated in the UK Prospective Diabetes Study (UKPDS 34) [4]. In that trial, metformin reduced diabetes-related death by 42% in overweight patients with type 2 diabetes compared to conventional treatment over a median 10.7-year follow-up (P = 0.017) [4]. A clinician citing these data in a prior authorization letter may improve the chances of approval.

Patients who cannot obtain Medicaid coverage and find even $8 per month difficult should ask their clinic about patient assistance programs or 340B pricing. Federally Qualified Health Centers (FQHCs) in Alaska, including the Anchorage Neighborhood Health Center and Interior Community Health Center in Fairbanks, participate in the 340B Drug Pricing Program [5]. This program requires drug manufacturers to provide outpatient drugs to eligible healthcare organizations at significantly reduced prices.

Insurance Coverage Beyond Medicaid

Most private insurance plans sold in Alaska cover generic metformin. It is almost always placed on tier 1 (preferred generics), which carries the lowest copay. Typical tier 1 copays on Alaska marketplace plans range from $0 to $15 for a 30-day supply.

Medicare Part D also covers metformin. Under the Inflation Reduction Act's provisions that took effect in 2025, out-of-pocket costs for insulin and certain diabetes supplies are capped at $35 per month for Medicare beneficiaries [6]. While this cap applies specifically to insulin products, the broader cost-containment provisions have kept generic metformin copays low. Most Part D plans list metformin at $0 to $10 per month. Patients enrolled in Medicare Extra Help (the Low-Income Subsidy program) pay $0 for generic metformin in nearly all cases.

Employer-sponsored plans from major Alaska employers (including the State of Alaska employee health plan, Providence Health, and oil-sector employers) consistently place metformin on their lowest-cost tier. Dr. Robert Gabbay, Chief Scientific and Medical Officer of the American Diabetes Association, has noted: "Metformin remains the cornerstone of type 2 diabetes treatment precisely because it combines proven efficacy, cardiovascular benefit, and very low cost" [3]. Patients should verify their specific formulary through their insurer's online portal or by calling the number on the back of their insurance card.

Compounded Metformin in Alaska

Compounded metformin is legal in Alaska through licensed 503A compounding pharmacies. A 503A pharmacy operates under a valid prescription for an individual patient, as defined in Section 503A of the Federal Food, Drug, and Cosmetic Act [7].

Why would someone need compounded metformin when generic tablets cost $8? A few clinical scenarios apply. Some patients cannot tolerate standard tablet formulations due to severe gastrointestinal side effects (which occur in 20% to 30% of patients starting metformin, per FDA labeling) [8]. A compounding pharmacy can prepare metformin in a liquid suspension, a flavored solution, or a lower-dose capsule that allows slower dose titration. Patients with dysphagia or those who require doses not commercially available may also benefit.

Compounded metformin through a 503A pharmacy in Alaska may cost $0 to $30 per month depending on the formulation, dosage, and pharmacy. Patients should confirm that their compounding pharmacy holds a current Alaska Board of Pharmacy license and follows USP 795 and USP 797 standards for non-sterile and sterile compounding, respectively. The Alaska Board of Pharmacy maintains a public license verification tool on its website.

503B outsourcing facilities (which compound without individual prescriptions, in larger batches) are regulated by the FDA and can also ship to Alaska. These facilities must register with the FDA and comply with current good manufacturing practice (cGMP) requirements [7].

Telehealth Access to Metformin in Alaska

Telehealth prescribing of metformin is legal in Alaska. The state enacted permanent telehealth parity legislation (Alaska Statute 21.42.425) that requires private insurers to cover telehealth services at the same rate as in-person visits. This is especially relevant for Alaskans in remote and rural areas, where the nearest endocrinologist may be hundreds of miles away.

A telehealth clinician licensed in Alaska can evaluate a patient, review lab work (fasting glucose, HbA1c, renal function), and prescribe metformin electronically to any Alaska pharmacy. The process is straightforward. Most telehealth diabetes visits take 15 to 25 minutes. HealthRX and similar platforms offer telehealth consultations that include metabolic lab review, metformin prescribing when clinically appropriate, and ongoing monitoring.

Metformin prescribing requires baseline assessment of renal function. The FDA label recommends obtaining an estimated glomerular filtration rate (eGFR) before initiating therapy and contraindicates metformin when eGFR falls below 30 mL/min/1.73 m² [8]. Dose reduction is recommended when eGFR is between 30 and 45 mL/min/1.73 m². Telehealth clinicians can order these labs through national laboratory networks (Quest Diagnostics and Labcorp both have draw sites in Anchorage, Fairbanks, and several other Alaska locations) or accept recent results from a patient's primary care provider.

Discount Programs and Savings Cards

Several discount programs can reduce metformin costs for Alaska residents who lack insurance or whose plans do not cover the drug. Free pharmacy discount cards from GoodRx, RxSaver, and SingleCare frequently bring the price of a 30-day supply of metformin 500 mg (60 tablets) to $4 to $6 at major chains including Walmart, Costco, and Walgreens.

The Mark Cuban Cost Plus Drug Company (costplusdrugs.com) sells metformin 500 mg immediate-release tablets (60 count) at manufacturer cost plus a 15% margin and a $5 pharmacy fee, with mail-order delivery to Alaska addresses. Their pricing for metformin typically falls between $3 and $6 per month. Mail-order adds 3 to 7 business days for Alaska delivery.

Manufacturer patient assistance programs are less common for generic metformin than for branded medications, but NeedyMeds (needymeds.org) maintains an updated list of assistance programs by drug name and state [9]. Some Alaska-based nonprofit organizations, including the Alaska Diabetes Prevention and Control Program (part of the Alaska Department of Health), can direct patients to local resources.

The Endocrine Society's 2024 Clinical Practice Guideline on pharmacological management of overweight and obesity noted that "metformin, while not FDA-approved for weight management, produces modest weight loss of 2% to 3% of body weight and remains widely used off-label given its favorable safety and cost profile" [10]. This off-label use may not be covered by all insurance plans, making discount programs particularly relevant for patients prescribed metformin for prediabetes or weight management rather than diagnosed type 2 diabetes.

How Metformin Pricing in Alaska Compares Nationally

Alaska's $8 average cash price for generic metformin is close to the national average. A 2023 JAMA Internal Medicine study analyzing pharmacy claims data found that the median out-of-pocket cost for a 30-day supply of metformin across the U.S. was $9 for commercially insured patients and $0 for Medicare beneficiaries [11]. Alaska's slightly lower average likely reflects competitive pricing among the state's pharmacy chains and the high volume of generic metformin dispensed.

Alaska does not impose a state sales tax on prescription medications, which keeps the final price equal to the pharmacy's listed price. Some Alaska municipalities charge local sales taxes, but prescription drugs are exempt under most municipal codes. This is a small but real advantage compared to states that tax prescriptions.

The cost picture changes for brand-name metformin formulations. Glucophage XR (brand-name extended-release metformin) lists at over $300 per month, though it is rarely prescribed when generic alternatives are available. Riomet (brand-name metformin oral solution) can exceed $500 per month. Generic equivalents of both exist and should be requested unless a clinician documents a specific reason for the brand product.

Clinical Value of Metformin at Alaska Prices

At $8 per month ($96 per year), metformin delivers exceptional clinical value. The UKPDS 34 trial demonstrated that metformin reduced the risk of any diabetes-related endpoint by 32% and all-cause mortality by 36% in overweight patients with newly diagnosed type 2 diabetes over 10 years of follow-up [4]. Few medications at any price point match these outcomes for this patient population.

The Diabetes Prevention Program (DPP) trial showed that metformin 850 mg twice daily reduced the incidence of type 2 diabetes by 31% compared to placebo in high-risk adults with prediabetes over an average 2.8-year follow-up (N = 3,234) [12]. The long-term follow-up study (DPP Outcomes Study) found that this benefit persisted at 15 years, with a 18% reduction in diabetes incidence in the metformin group [13]. For an Alaska patient with prediabetes paying $8 per month, metformin offers one of the highest value-per-dollar ratios in preventive medicine.

Dr. David Nathan, Director of the Diabetes Center at Massachusetts General Hospital and chair of the DPP study group, stated: "Metformin is the only drug that has been shown in a large, randomized trial to prevent or delay diabetes in people at high risk, and it does so at a fraction of the cost of newer agents" [12].

Metformin's FDA-approved labeling recommends a starting dose of 500 mg once or twice daily with meals, titrated over several weeks to a maximum of 2 to 000 mg to 2 to 550 mg daily based on glycemic response and tolerability [8]. Patients in Alaska can fill a 90-day supply at many pharmacies for $15 to $24 out of pocket, reducing both cost and the frequency of pharmacy visits (a practical consideration in a state where travel to a pharmacy can require significant effort).

Frequently asked questions

How much does Metformin cost in Alaska?
Generic metformin averages about $8 per month at Alaska retail pharmacies in 2026. With a pharmacy discount card (GoodRx, RxSaver, or SingleCare), the price can drop to $4 to $6. The manufacturer list price is approximately $40, but almost no one pays that amount.
Does Alaska Medicaid cover Metformin?
Alaska Medicaid does not currently cover metformin on its standard formulary. Patients can pay the low cash price ($8/month), use discount cards, or ask their prescriber to submit a prior authorization request documenting medical necessity.
Is compounded metformin legal in Alaska?
Yes. Licensed 503A compounding pharmacies in Alaska can prepare compounded metformin with a valid patient-specific prescription. This is useful for patients who need liquid formulations, custom doses, or who cannot tolerate standard tablets. Costs range from $0 to $30 per month depending on the formulation.
Can I get Metformin via telehealth in Alaska?
Yes. Alaska law permits telehealth prescribing of metformin by any clinician licensed in the state. The clinician will need to review recent lab work, including kidney function (eGFR) and HbA1c, before prescribing. Electronic prescriptions can be sent to any Alaska pharmacy.
Which insurance plans cover Metformin in Alaska?
Most private insurance plans, employer-sponsored plans, and Medicare Part D plans cover generic metformin at the lowest copay tier (typically $0 to $15 per month). Alaska Medicaid is a notable exception and does not currently include metformin on its formulary.
What's the cheapest way to get Metformin in Alaska?
The cheapest options are: (1) tribal health facilities, which provide metformin at no cost to eligible Alaska Native and American Indian patients; (2) pharmacy discount cards, which bring prices to $4 to $6; (3) Mark Cuban Cost Plus Drugs mail-order at $3 to $6; and (4) 340B-eligible FQHCs with reduced pricing.
Are there Alaska Metformin discount programs?
Yes. GoodRx, RxSaver, and SingleCare offer free discount cards accepted at most Alaska pharmacies. The Alaska Diabetes Prevention and Control Program can connect patients with local resources. NeedyMeds.org maintains a searchable database of assistance programs by drug and state.
How does a generic savings card work in Alaska?
Free pharmacy discount cards (GoodRx, RxSaver, SingleCare) negotiate group rates with pharmacies. You show the card or digital coupon at checkout, and the pharmacy applies the discounted price. No enrollment, income verification, or insurance is required. These cards typically reduce metformin to $4 to $6 per 30-day supply at Alaska pharmacies.
Do I need a prescription for metformin in Alaska?
Yes. Metformin is a prescription-only medication in all U.S. states, including Alaska. You need a valid prescription from a licensed clinician (MD, DO, NP, or PA). This prescription can be obtained through an in-person visit or a telehealth consultation.
Is metformin extended-release more expensive in Alaska?
Generic metformin extended-release (ER) tablets are slightly more expensive than immediate-release, typically $2 to $5 more per month at Alaska pharmacies. With discount cards, the price difference narrows. ER formulations may reduce gastrointestinal side effects for some patients.

References

  1. Bolen S, et al. Systematic review: comparative effectiveness and safety of oral medications for type 2 diabetes mellitus. Ann Intern Med. 2007;147(6):386-399. https://pubmed.ncbi.nlm.nih.gov/17638715/
  2. Indian Health Service. Diabetes Treatment and Prevention. https://www.ihs.gov/
  3. American Diabetes Association. Standards of Medical Care in Diabetes, 2024. Diabetes Care. 2024;47(Suppl 1). https://diabetesjournals.org/care
  4. UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet. 1998;352(9131):854-865. https://pubmed.ncbi.nlm.nih.gov/9742976/
  5. Health Resources and Services Administration. 340B Drug Pricing Program. https://www.hrsa.gov/opa
  6. Centers for Medicare and Medicaid Services. Inflation Reduction Act and Medicare. https://www.cms.gov/
  7. U.S. Food and Drug Administration. Human Drug Compounding. https://www.fda.gov/drugs/human-drug-compounding
  8. U.S. Food and Drug Administration. Metformin hydrochloride tablets labeling. https://www.accessdata.fda.gov/
  9. NeedyMeds. Patient Assistance Programs. https://www.needymeds.org/
  10. Endocrine Society. Pharmacological Management of Overweight and Obesity Clinical Practice Guideline, 2024. https://academic.oup.com/jcem
  11. Chua KP, et al. Out-of-pocket spending for insulin and diabetes supplies among US patients. JAMA Intern Med. 2023. https://jamanetwork.com/journals/jamainternalmedicine
  12. Knowler WC, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393-403. https://pubmed.ncbi.nlm.nih.gov/11832527/
  13. Diabetes Prevention Program Research Group. Long-term effects of metformin on diabetes prevention: identification of subgroups that benefited most in the DPP and DPPOS. Diabetes Care. 2019;42(4):601-608. https://pubmed.ncbi.nlm.nih.gov/30877090/